Rab GDI α Activators
Rab GDI α Activators comprise a diverse array of chemical compounds that indirectly augment the functional activity of Rab GDI α, a protein pivotal in membrane trafficking and vesicle movement. Forskolin, by elevating intracellular cAMP levels, indirectly promotes Rab GDI α's function by activating protein kinase A (PKA), which phosphorylates various substrates that could modify Rab GDI α's interactions with Rab proteins. Similarly, D-erythro-Sphingosine-1-phosphate influences membrane lipid composition, potentially altering Rab protein localization and enhancing Rab GDI α activity. The calcium ionophore Ionomycin elevates intracellular calcium levels, impacting calcium-dependent signaling pathways, which in turn may affect Rab GDI α's role in regulating Rab protein cycling. Additionally, PMA, by activating protein kinase C (PKC), could influence Rab GDI α's interaction with Rab proteins, thereby modifying its functional role in vesicle trafficking.
Further influencing Rab GDI α's activity are compounds that modulate intracellular signaling pathways. LY 294002 and Wortmannin, both PI3K inhibitors, can indirectly impact Rab GDI α by altering signaling pathways that influence membrane trafficking, a key process in which Rab GDI α is involved. U-73122, a PLC inhibitor, and Genistein, a tyrosine kinase inhibitor, affect phospholipid and phosphorylation signaling respectively, thereby potentially altering Rab GDI α's interactions with Rab proteins. The cAMP analog 8-Bromoadenosine 3',5'-cyclic monophosphate and the Gs alpha subunit inhibitor NF449 modulate signaling through PKA and G protein-coupled receptors, respectively, influencing the dynamics of membrane systems where Rab GDI α operates. Gö 6976, a PKC inhibitor, and YM-254890, a Gq alpha subunit inhibitor, further modulate signaling pathways that could indirectly enhance Rab GDI α's activity in membrane trafficking and vesicle movement, demonstrating the complex interplay of intracellular signaling in regulating the activity of this crucial protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances Rab GDI α activity by increasing cAMP levels, which in turn activates PKA. PKA phosphorylates various proteins, potentially influencing the membrane association and dissociation dynamics of Rab GDI α with Rab proteins. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule enhances Rab GDI α activity by modulating membrane lipid composition, potentially altering Rab protein localization and Rab GDI α interactions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium, influencing calcium-dependent signaling pathways that could affect membrane trafficking and Rab GDI α's role in Rab protein cycling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can phosphorylate substrates involved in membrane trafficking, potentially altering Rab GDI α's interaction with Rab proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY 294002 modifies intracellular signaling, potentially impacting Rab GDI α's role in membrane trafficking and vesicle movement. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
By inhibiting tyrosine kinases, Genistein may influence Rab GDI α's activity by altering the phosphorylation status of proteins involved in membrane trafficking and vesicle dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, as a PI3K inhibitor, can indirectly influence Rab GDI α activity by altering signaling pathways that impact membrane trafficking and Rab protein cycling. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analog enhances PKA activity, which could influence Rab GDI α's interaction with Rab proteins in membrane trafficking through phosphorylation events. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
NF449, a Gs alpha subunit inhibitor, may indirectly influence Rab GDI α activity by modulating G protein-coupled receptor signaling, potentially affecting membrane dynamics where Rab GDI α operates. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö 6976, a PKC inhibitor, may indirectly enhance Rab GDI α activity by modifying phosphorylation events in pathways involved in membrane trafficking. | ||||||